By participating in a clinical trial a patient gains access to treatments or procedures not yet available in the community. In fact, Michigan Vascular Center has taken a leadership role in bringing state-of-the-art endovascular treatments to Michigan:
- First in Michigan to implant a FDA approved carotid stent manufactured by Guidant, Inc. in September 2004.
- First site in Michigan to implant a superficial femoral artery drug-coated stent manufactured by Cook, Inc. in October 2005.
- First in Michigan to implant a FDA approved abdominal aortic aneurysm pressure monitoring device, manufactured by CardioMEMS in June 2006. This device is placed in the AAA sac at the time of endograft repair in order to remotely measure sac pressure over time.
Since its formation in 1998, we have participated in numerous device, drug and investigator-initiated trials. Without clinical research, medical and surgical innovations could not occur. Because our generation and generations to come rely on today’s clinical research efforts, we are committed to offering innovative and otherwise unavailable treatments to our patients.